Predicted to be located in mitochondrial matrix. Expressed in several structures, including GABAergic neurons; head muscle; head neurons; intestinal cell; and pharyngeal cell.
Predicted to enable G protein-coupled peptide receptor activity. Predicted to be involved in neuropeptide signaling pathway. Predicted to be located in membrane. Expressed in GABAergic neurons and tail.
Predicted to enable calcium ion binding activity. Expressed in GABAergic neurons; cholinergic neurons; motor neurons; nervous system; and ventral nerve cord. Is an ortholog of human RCVRN (recoverin).
Enriched in GABAergic neurons based on RNA-seq studies. Is affected by several genes including drh-3; let-418; and ubc-9 based on tiling array; microarray; and RNA-seq studies.
Enriched in GABAergic neurons based on RNA-seq studies. Is affected by lag-1 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.
Involved in several processes, including positive regulation of protein localization to presynapse; positive regulation of synapse pruning; and secretion by cell. Located in mitochondrion and synapse. Expressed in GABAergic neurons; cholinergic neurons; and head muscle.
Predicted to enable ATP binding activity; phosphatidylinositol binding activity; and protein kinase activity. Expressed in GABAergic neurons; rectal muscle; retrovesicular ganglion; and somatic nervous system. Is an ortholog of human RPS6KC1 (ribosomal protein S6 kinase C1).
Enriched in AVE; GABAergic neurons; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by Colistin based on microarray studies.